pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Preclinical
LXM-2
Diabetes
Laxxon Medical GmbH
0 catalysts
Preclinical
LXP-103
Obesity
LaunXP Biomedical Co Ltd
0 catalysts
Phase 2
LXP-109
Non-Small Cell Lung Cancer
LaunXP Biomedical Co Ltd
0 catalysts
Phase 2
LXP-5268
Triple-Negative Breast Cancer (TNBC)
LaunXP Biomedical Co Ltd
← prev
page 120 of 271
next →
131
Pain89
Neurology1
0 catalysts
LYBALVI
LYBALVI (OLANZAPINE)
1 INDICATIONS AND USAGE LYBALVI is indicated for the treatment of: Schizophre…
D2-like dopamine receptor5-hydroxytryptamine receptor 2C
$ALKSAlkermes plc.
0 catalysts
Phase 2
LYGLIV-0001
Liver Diseases
LyGenesis Inc
0 catalysts
Phase 1
LYL-273
Metastatic Colorectal Cancer
$LYELLyell Immunopharma, Inc.
0 catalysts
LYNAVOY
LYNAVOY (LINERIXIBAT)
GlaxoSmithKline LLC
0 catalysts
Phase 2
LYT-200
Liver Cancer
Gallop Oncology Inc
0 catalysts
LYTGOBI
LYTGOBI (FUTIBATINIB)
Taiho Oncology Inc
0 catalysts
Phase 1
LZ-001
Non-Small Cell Lung Cancer
Livzon Pharmaceutical Group Inc
0 catalysts
Marketed
Labetalol Hydrochloride Hikma
Labetalol Hydrochloride (labetalol hydrochloride)
Hypertension
Hikma Pharmaceuticals USA Inc
0 catalysts
pre_registration
Lagevrio
Lagevrio (molnupiravir)
Coronavirus Disease 2019 (COVID-19)
$MRKMerck & Co., Inc.
0 catalysts
Marketed
Lanreotide Acetate Cipla
Lanreotide Acetate (lanreotide acetate)
Acromegaly
InvaGen Pharmaceuticals Inc
0 catalysts
Marketed
Larotid
Amoxil (amoxicillin)
Bacterial Vaginosis
GlaxoSmithKline LLC
0 catalysts
Preclinical
Lead Candidate
Parkinson's Disease
MaavRx Ltd
0 catalysts
Preclinical
Lead Program
Corneal Degeneration
2A Biosciences Inc
0 catalysts
Marketed
Lemtrada
Lemtrada (alemtuzumab)
Relapsing Remitting Multiple Sclerosis (RRMS)
Genzyme Corp
0 catalysts
Marketed
Leucovorin Calcium Teva
Leucovorin Calcium (leucovorin calcium)
Megaloblastic Anemia
Teva Pharmaceuticals USA Inc
0 catalysts
Marketed
Levolet
Levolet (levothyroxine sodium)
Goiter
Genus Lifesciences Inc
0 catalysts
Marketed
Levoxyl
Levoxyl (levothyroxine sodium)
Goiter
$PFEPFIZER INC
0 catalysts
Marketed
Lexapro
Lexapro (escitalopram oxalate)
Generalized Anxiety Disorder (GAD)
$ABBVAbbVie Inc.
0 catalysts
Marketed
Lialda ER
Lialda (mesalamine)
Ulcerative Colitis
Takeda Pharmaceuticals USA Inc
0 catalysts
Marketed
Linisol
Lidocaine Hydrochloride (lidocaine hydrochloride)
Local Anesthetic Effect
B. Braun Medical Inc
0 catalysts
pre_registration
LipidRescue
Drug Toxicity
ResQ Pharma Inc
0 catalysts
Marketed
Lipitor
Lipitor (atorvastatin calcium)
Cardiovascular Risk Factors
$VTRSViatris Inc
0 catalysts
Marketed
Lodoco
Lodoco (colchicine)
Cardiovascular Risk Factors
Agepha Pharma sro
0 catalysts
Marketed
Loestrin
Taytulla ((ethinylestradiol + norethindrone))
Female Contraception
Allergan Sales LLC
0 catalysts
Marketed
Lomotil
Lomotil ((atropine sulfate + diphenoxylate [INN]))
Diarrhea
$PFEPFIZER INC
0 catalysts
Marketed
Loperamide Hydrochloride Bionpharma
Loperamide Hydrochloride (loperamide hydrochloride)
Diarrhea
Bionpharma Inc
0 catalysts